Skip to main content
Premium Trial:

Request an Annual Quote

Clear Labs Raises $60M in Series C Financing Round

NEW YORK – Molecular food safety testing company Clear Labs announced on Wednesday that it has raised $60 million in an oversubscribed Series C financing round to advance its genomic surveillance products for SARS-CoV-2.

The round was co-led by Counterpoint Global and funds and accounts advised by T. Rowe Price Associates, with participation from existing investors including Redmile Group, Menlo Ventures, Wing Ventures, HBM Genomics, Khosla Ventures, Felicis Ventures, and Dafgard.

The funding will be used to help increase the availability of the company's solutions to help labs and clinicians "more easily identify and trace all strains of pathogens, like SARS-CoV-2," Clear Labs said in a statement.

The company will continue to develop its capabilities so it "can deliver the early warning system, enhanced real-time genomic surveillance of the pathogen(s) and in-depth variant tracking that the public and private health communities need," Clear Labs CEO Sasan Amini said in a statement.

The San Carlos, California-based company's Clear Dx Whole Genome Sequencing workflow solution determines the complete RNA sequence of the SARS-CoV-2 genome in 24 hours and can differentiate viral strains and monitor mutations that can lead to variants.

Clear Labs also received Emergency Use Authorization from the US Food and Drug Administration in September for its Clear Dx SARS-CoV-2 nanopore sequencing test that allows labs to perform diagnostic screening and genomic surveillance simultaneously.

Last May, the firm raised $18 million in a strategic funding round to commercialize its SARS-CoV-2 platform.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.